Skip to main content
Livermore
Livermore
ZHEN

Leonteq Securities AG

SEC CIK
0001535950
Latest filing
Jul 27, 2026

IOVA holding history

Iovance Biotherapeutics, Inc. in every 13F filed by Leonteq Securities AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings

Shares (Q2 2026)
150,000
Value
$624.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of IOVA by Leonteq Securities AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026150,000$624.0K<0.1%−10,000−6.3%ReducedHolders
Q1 2026160,000$561.6K<0.1%−35,000−17.9%ReducedHolders
Q4 2025195,000$532.4K<0.1%+100,000+105.3%AddedHolders
Q3 202595,000$206.2K<0.1%00.0%UnchangedHolders
Q2 202595,000$163.4K<0.1%+95,000NewHolders
Q1 20250$00.0%−29,000−100.0%Sold outHolders
Q4 202429,000$214.6K<0.1%−11,000−27.5%ReducedHolders
Q3 202440,000$375.6K<0.1%00.0%UnchangedHolders
Q2 202440,000$320.8K<0.1%+9,800+32.5%AddedHolders
Q1 202430,200$447.6K0.1%−19,800−39.6%ReducedHolders
Q4 202350,000$406.5K0.1%+8,587+20.7%AddedHolders
Q3 202341,413$188.4K<0.1%+30,609+283.3%AddedHolders
Q2 202310,804$76.1K<0.1%+8,473+363.5%AddedHolders
Q1 20232,331$14.2K<0.1%−14,233−85.9%ReducedHolders
Q4 202216,564$105.8K<0.1%+8,542+106.5%AddedHolders
Q3 20228,022$76.9K<0.1%−1,601−16.6%ReducedHolders
Q2 20229,623$106.2K<0.1%−261−2.6%ReducedHolders
Q1 20229,884$164.6K<0.1%−480−4.6%ReducedHolders
Q4 202110,364$197.8K<0.1%−994−8.8%ReducedHolders
Q3 202111,358$280.1K<0.1%−2,724−19.3%ReducedHolders
Q2 202114,082$366.4K<0.1%+14,055+52,055.6%AddedHolders
Q1 202127$855<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.